Migraine is first cause of disability in under 50s: will health politicians now take notice?

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220 · see citing works

Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

Arnold, M. (2018) · Cephalalgia · doi:10.1177/0333102417738202 · Cited by 11,090 · see citing works

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291 · see citing works

The International Classification of Headache Disorders, 3rd edition (beta version)

Headache Classification Committee of the International Headache Society (IHS) (2013) · Cephalalgia · doi:10.1177/0333102413485658 · Cited by 8,229 · see citing works

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253 · see citing works

Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414 · see citing works

The global burden of headache: A documentation of headache prevalence and disability worldwide

Stovner, L., Hagen, K., Jensen, R., Katsarava, Z., Lipton, R., Scher, A., Steiner, T., & Zwart, J.-A. (2007) · Cephalalgia · doi:10.1111/j.1468-2982.2007.01288.x · Cited by 2,444 · see citing works

World Health Report

Prentice, T. (2013) · Res Medica · doi:10.2218/resmedica.v21i1.510 · Cited by 1,710 · see citing works

The World Health Report 2001

Bebbington, P. (2001) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270170010 · Cited by 515 · see citing works

The impact of headache in Europe: principal results of the Eurolight project

Steiner, T. J., Stovner, L. J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Tassorelli, C., Barré, J., et al. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-31 · Cited by 382 · cited 2× · see citing works

Migraine: the seventh disabler

Steiner, T. J., Stovner, L. J., & Birbeck, G. L. (2013) · The Journal of Headache and Pain · doi:10.1186/1129-2377-14-1 · Cited by 335 · see citing works

Poor medical care for people with migraine in Europe – evidence from the Eurolight study

Katsarava, Z., Mania, M., Lampl, C., Herberhold, J., & Steiner, T. J. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0839-1 · Cited by 309 · see citing works

Lifting the burden: the global campaign against headache

Steiner, T. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00703-3 · Cited by 271 · see citing works

Chronic daily headache with analgesic overuse

Colás, R., Muñoz, P., Temprano, R. P., Gómez, C., & Pascual, J. (2004) · Neurology · doi:10.1212/01.wnl.0000120545.45443.93 · Cited by 264 · see citing works

Headache disorders are third cause of disability worldwide

Steiner, T. J., Birbeck, G. L., Jensen, R., Katsarava, Z., Stovner, L. J., & Martelletti, P. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0544-2 · Cited by 262 · see citing works

Medication Overuse Headache: Rates and Predictors for Relapse in a 4-year Prospective Study

Katsarava, Z., Muessig, M., Dzagnidze, A., Fritsche, G., Diener, H., & Limmroth, V. (2004) · Cephalalgia · doi:10.1111/j.1468-2982.2004.00789.x · Cited by 226 · see citing works

Diagnosis, prevalence estimation and burden measurement in population surveys of headache: presenting the HARDSHIP questionnaire

Steiner, T. J., Gururaj, G., Andrée, C., Katsarava, Z., Ayzenberg, I., Yu, S.-Y., Al Jumah, M., Tekle-Haimanot, R., Birbeck, G. L., Herekar, A., et al. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-3 · Cited by 204 · see citing works

The methodology of population surveys of headache prevalence, burden and cost: Principles and recommendations from the Global Campaign against Headache

Stovner, L. J., Al Jumah, M., Birbeck, G. L., Gururaj, G., Jensen, R., Katsarava, Z., Queiroz, L. P., Scher, A. I., Tekle-Haimanot, R., Wang, S.-J., et al. (2014) · The Journal of Headache and Pain · doi:10.1186/1129-2377-15-5 · Cited by 203 · see citing works

Lifting The Burden: The Global Campaign to Reduce the Burden of Headache Worldwide

Steiner, T. (2005) · The Journal of Headache and Pain · doi:10.1007/s10194-005-0241-7 · Cited by 172 · see citing works

Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: A systematic review

Westergaard, M. L., Hansen, E. H., Glümer, C., Olesen, J., & Jensen, R. (2013) · Cephalalgia · doi:10.1177/0333102413512033 · Cited by 166 · see citing works

Interictal burden attributable to episodic headache: findings from the Eurolight project

Lampl, C., Thomas, H., Stovner, L. J., Tassorelli, C., Katsarava, Z., Laínez, J. M., Lantéri-Minet, M., Rastenyte, D., Ruiz de la Torre, E., Andrée, C., et al. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0599-8 · Cited by 149 · see citing works

Genetics of tension-type headache

Russell, M. B. (2007) · The Journal of Headache and Pain · doi:10.1007/s10194-007-0366-y · Cited by 135 · see citing works

Epidemiology of medication overuse headache in the general Swedish population

Jonsson, P., Hedenrud, T., & Linde, M. (2011) · Cephalalgia · doi:10.1177/0333102411410082 · Cited by 127 · see citing works

The Global Campaign, World Health Organization and Lifting The Burden: collaboration in action

Steiner, T. J., Birbeck, G. L., Jensen, R., Katsarava, Z., Martelletti, P., & Stovner, L. J. (2011) · The Journal of Headache and Pain · doi:10.1007/s10194-011-0342-4 · Cited by 90 · see citing works

Lifting The Burden: the first 7 years

Steiner, T. J., Birbeck, G. L., Jensen, R., Katsarava, Z., Martelletti, P., & Stovner, L. J. (2010) · The Journal of Headache and Pain · doi:10.1007/s10194-010-0264-6 · Cited by 80 · see citing works

The Eurolight project: the impact of primary headache disorders in Europe. Description of methods

Andrée, C., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lanteri-Minet, M., Mick, G., Rastenyte, D., de la Torre, E. R., et al. (2011) · The Journal of Headache and Pain · doi:10.1007/s10194-011-0356-y · Cited by 60 · see citing works

Cost-effectiveness analysis of interventions for migraine in four low- and middle-income countries

Linde, M., Steiner, T. J., & Chisholm, D. (2015) · The Journal of Headache and Pain · doi:10.1186/s10194-015-0496-6 · Cited by 53 · see citing works

Time to act on headache disorders

Steiner, T. J., Stovner, L. J., Dua, T., Birbeck, G. L., Jensen, R., Katsarava, Z., Martelletti, P., & Saxena, S. (2011) · The Journal of Headache and Pain · doi:10.1007/s10194-011-0368-7 · Cited by 35 · see citing works

Neglected headache: Ignorance, arrogance or insouciance?

Katsarava, Z., & Steiner, T. J. (2012) · Cephalalgia · doi:10.1177/0333102412459478 · Cited by 26 · see citing works

Consensus Statement on Improving Migraine Management

American Association for the Study of Headache International Headache Society (1998) · Headache The Journal of Head and Face Pain · doi:10.1046/j.1526-4610.1998.t01-1-3810736.x · Cited by 26 · see citing works

Can we know the prevalence of MOH?

Steiner, T. (2014) · Cephalalgia · doi:10.1177/0333102414520768 · Cited by 23 · see citing works

Migraine – the forgotten epidemic: development of the EHF/WHA Rome Declaration on Migraine

Diener, H. C., Steiner, T., & Tepper, S. J. (2006) · The Journal of Headache and Pain · doi:10.1007/s10194-006-0349-4 · Cited by 15 · see citing works

Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

Stovner, L. J., Nichols, E. L., Steiner, T. J., Abd-Allah, F., Abdelalim, A., Al-Raddadi, R. M., Ansha, M. G., Barac, A. M., Benseñor, I. M., Doan, L. P., et al. (2018) · The Lancet Neurology · doi:10.1016/s1474-4422(18)30322-3 · Cited by 1,912 · see citing works

Migraine remains second among the world’s causes of disability, and first among young women: findings from GBD2019

Headache, O. B. O. L. T. B. T. G. C. A., Steiner, T. J., Stovner, L. J., Jensen, R., Uludüz, D., & Katsarava, Z. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01208-0 · Cited by 1,049 · see citing works

Fremanezumab versus placebo for migraine prevention in patients with documented failure to up to four migraine preventive medication classes (FOCUS): a randomised, double-blind, placebo-controlled, phase 3b trial

Ferrari, M. D., Diener, H., Ning, X., Galić, M., Cohen, J. M., Yang, R., Müeller, M., Ahn, A. H., Schwartz, Y. C., Grozinski‐Wolff, M., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31946-4 · Cited by 416 · see citing works

Gut-brain Axis and migraine headache: a comprehensive review

On behalf of the School of Advanced Studies of the European Headache Federation (EHF-SAS), Arzani, M., Jahromi, S. R., Ghorbani, Z., Vahabizad, F., Martelletti, P., Ghaemi, A., Sacco, S., & Togha, M. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-1078-9 · Cited by 366 · see citing works

Migraine: integrated approaches to clinical management and emerging treatments

Ashina, M., Buse, D. C., Ashina, H., Pozo‐Rosich, P., Peres, M. F. P., Lee, M. J., Terwindt, G. M., Singh, R. B. H., Tassorelli, C., Do, T. P., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(20)32342-4 · Cited by 311 · see citing works

A narrative review on the burden of migraine: when the burden is the impact on people’s life

Leonardi, M., & Raggi, A. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0993-0 · Cited by 292 · see citing works

Understanding the nature of psychiatric comorbidity in migraine: a systematic review focused on interactions and treatment implications

Dresler, T., Caratozzolo, S., Guldolf, K., Huhn, J.-I., Loiacono, C., Niiberg-Pikksööt, T., Puma, M., Sforza, G., Tobia, A., Ornello, R., et al. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0988-x · Cited by 246 · see citing works

My Migraine Voice survey: a global study of disease burden among individuals with migraine for whom preventive treatments have failed

Martelletti, P., Schwedt, T. J., Lanteri-Minet, M., Quintana, R., Carboni, V., Diener, H.-C., Ruiz de la Torre, E., Craven, A., Rasmussen, A. V., Evans, S., et al. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0946-z · Cited by 217 · see citing works

Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial

Xu, S., Yu, L., Luo, X., Wang, M., Chen, G., Zhang, Q., Liu, W., Zhou, Z., Song, J., Jing, H.-T., et al. (2020) · BMJ · doi:10.1136/bmj.m697 · Cited by 217 · see citing works

Pharmacological treatment of migraine: CGRP and 5-HT beyond the triptans

de Vries, T., Villalón, C. M., & MaassenVanDenBrink, A. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107528 · Cited by 215 · see citing works

Dural Calcitonin Gene-Related Peptide Produces Female-Specific Responses in Rodent Migraine Models

Avona, A., Burgos-Vega, C., Burton, M. D., Akopian, A. N., Price, T. J., & Dussor, G. O. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0364-19.2019 · Cited by 199 · see citing works

Hormonal influences in migraine — interactions of oestrogen, oxytocin and CGRP

Krause, D. N., Warfvinge, K., Haanes, K. A., & Edvinsson, L. I. (2021) · Nature Reviews Neurology · doi:10.1038/s41582-021-00544-2 · Cited by 207 · see citing works

The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis

Lemmens, J., Pauw, J. D., Soom, T. V., Michiels, S., Versijpt, J. J., van Breda, E., Castien, R., & Hertogh, W. D. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0961-8 · Cited by 184 · see citing works

Migraine in America Symptoms and Treatment (MAST) Study: Baseline Study Methods, Treatment Patterns, and Gender Differences

Lipton, R. B., Munjal, S., Alam, A., Buse, D. C., Fanning, K. M., Reed, M. L., Schwedt, T. J., & Dodick, D. W. (2018) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13407 · Cited by 182 · see citing works

Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy

Ornello, R., Casalena, A., Frattale, I., Gabriele, A., Affaitati, G., Giamberardino, M. A., Assetta, M., Maddestra, M., Marzoli, F., Viola, S., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01102-9 · Cited by 164 · see citing works

Safety and tolerability of monoclonal antibodies targeting the CGRP pathway and gepants in migraine prevention: A systematic review and network meta-analysis

Messina, R., Huessler, E., Puledda, F., Haghdoost, F., Lebedeva, E. R., & Diener, H. (2023) · Cephalalgia · doi:10.1177/03331024231152169 · Cited by 155 · see citing works

Patients’ perspective on the burden of migraine in Europe: a cross-sectional analysis of survey data in France, Germany, Italy, Spain, and the United Kingdom

Vo, P. G., Fang, J., Bilitou, A., Laflamme, A. K., & Gupta, S. (2018) · The Journal of Headache and Pain · doi:10.1186/s10194-018-0907-6 · Cited by 153 · see citing works

Association of diet and headache

Jahromi, S. R., Ghorbani, Z., Martelletti, P., Lampl, C., & Togha, M. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1057-1 · Cited by 151 · see citing works

Current understanding of meningeal and cerebral vascular function underlying migraine headache

Levy, D., Labastida‐Ramírez, A., & MaassenVanDenBrink, A. (2018) · Cephalalgia · doi:10.1177/0333102418771350 · Cited by 129 · see citing works

Poor patient awareness and frequent misdiagnosis of migraine: findings from a large transcontinental cohort

Viana, M., Khaliq, F., Zecca, C., Figuerola, M. D. L., Sances, G., Piero, V. D., Petolicchio, B., Alessiani, M., Geppetti, P., Lupi, C., et al. (2019) · European Journal of Neurology · doi:10.1111/ene.14098 · Cited by 118 · see citing works

Efficacy of psychological treatment for headache disorder: a systematic review and meta-analysis

Lee, H. J., Lee, J. H., Cho, E. Y., Kim, S. M., & Yoon, S. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0965-4 · Cited by 102 · see citing works

Differences in treatment response between migraine with aura and migraine without aura: lessons from clinical practice and RCTs

Hansen, J. M., & Charles, A. C. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1046-4 · Cited by 97 · see citing works

Meningeal CGRP ‐Prolactin Interaction Evokes Female‐Specific Migraine Behavior

Avona, A., Mason, B. N., Burgos-Vega, C., Hovhannisyan, A. H., Belugin, S., Mecklenburg, J. M., Goffin, V., Wajahat, N., Price, T. J., Akopian, A. N., et al. (2021) · Annals of Neurology · doi:10.1002/ana.26070 · Cited by 97 · see citing works

Content Validity of HIT‐6 as a Measure of Headache Impact in People With Migraine: A Narrative Review

Houts, C. R., Wirth, R. J., McGinley, J. S., Gwaltney, C. J., Kassel, E., Snapinn, S. M., & Cady, R. K. (2019) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13701 · Cited by 96 · see citing works

The role of nutrients in the pathogenesis and treatment of migraine headaches: Review

Nattagh‐Eshtivani, E., Sani, M. A., Dahri, M., Ghalichi, F., Ghavami, A., Arzhang, P., & Tarighat‐Esfanjani, A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.059 · Cited by 92 · see citing works

Cost of chronic and episodic migraine patients in continuous treatment for two years in a tertiary level headache Centre

Negro, A., Sciattella, P., Rossi, D., Guglielmetti, M., Martelletti, P., & Mennini, F. S. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1068-y · Cited by 89 · see citing works

Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis

Drellia, K., Kokoti, L., Deligianni, C. I., Papadopoulos, D., & Mitsikostas, D. D. (2021) · Cephalalgia · doi:10.1177/0333102421989601 · Cited by 88 · see citing works

Co-occurrence of pain syndromes

Affaitati, G., Costantini, R., Tana, C., Cipollone, F., & Giamberardino, M. A. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-02107-8 · Cited by 87 · see citing works

Physical therapy and migraine: musculoskeletal and balance dysfunctions and their relevance for clinical practice

Carvalho, G. F., Schwarz, A., Szikszay, T. M., Adamczyk, W. M., Bevilaqua‐Grossi, D., & Luedtke, K. (2019) · Brazilian Journal of Physical Therapy · doi:10.1016/j.bjpt.2019.11.001 · Cited by 91 · see citing works

Vitamin D in migraine headache: a comprehensive review on literature

Ghorbani, Z., Togha, M., Rafiee, P., Ahmadi, Z. S., Rasekhmagham, R., Haghighi, S., Jahromi, S. R., & Mahmoudi, M. (2019) · Neurological Sciences · doi:10.1007/s10072-019-04021-z · Cited by 83 · see citing works

Botulinum Toxin in the Treatment of Headache

Becker, W. J. (2020) · Toxins · doi:10.3390/toxins12120803 · Cited by 81 · see citing works

The prevalence of primary headache disorders in Saudi Arabia: a cross-sectional population-based study

Jumah, M. A., Khathaami, A. M. A., Kojan, S., Hussain, M., Thomas, H., & Steiner, T. J. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-1081-1 · Cited by 80 · see citing works

Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application

Vo, P. G., Paris, N., Bilitou, A., Valena, T., Fang, J., Naujoks, C., Cameron, A. E., de Vulpillieres, F. D. R., & Cadiou, F. (2018) · Neurology and Therapy · doi:10.1007/s40120-018-0113-0 · Cited by 76 · see citing works

Headache in Children and Adolescents

Szperka, C. L. (2021) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000993 · Cited by 77 · see citing works

Characterization of Ubrogepant: A Potent and Selective Antagonist of the Human Calcitonin Gene‒Related Peptide Receptor

Moore, E. L., Fraley, M. E., Bell, I. M., Burgey, C. S., White, R. B., Li, C., Regan, C. P., Danziger, A., Michener, M. S., Hostetler, E. D., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.261065 · Cited by 76 · see citing works

New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies

Scuteri, D., Adornetto, A., Rombolà, L., Naturale, M. D., Morrone, L. A., Bagetta, G., Tonin, P., & Corasaniti, M. T. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00363 · Cited by 74 · see citing works

An investigation of oxidant/antioxidant balance in patients with migraine: a case-control study

Togha, M., Jahromi, S. R., Ghorbani, Z., Ghaemi, A., & Rafiee, P. (2019) · BMC Neurology · doi:10.1186/s12883-019-1555-4 · Cited by 73 · see citing works

Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description

Steiner, T. J., Jensen, R., Katsarava, Z., Stovner, L. J., Uludüz, D., Adarmouch, L., Jumah, M. A., Khathaami, A. M. A., Ashina, M., Braschinsky, M., et al. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01265-z · Cited by 72 · see citing works

Safety and efficacy of rimegepant orally disintegrating tablet for the acute treatment of migraine in China and South Korea: a phase 3, double-blind, randomised, placebo-controlled trial

Yu, S., Kim, B., Guo, A., Kim, M., Zhang, M., Wang, Z., Liu, J., Moon, H., Tan, G., Yang, Q., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00126-6 · Cited by 71 · see citing works

Migraine management: Non-pharmacological points for patients and health care professionals

Haghdoost, F., & Togha, M. (2022) · Open Medicine · doi:10.1515/med-2022-0598 · Cited by 70 · see citing works

Global, regional, and national burden and trends of migraine among youths and young adults aged 15–39 years from 1990 to 2021: findings from the global burden of disease study 2021

Chen, Z., Kong, X.-M., Yang, C., Li, X., Guo, H. Y., & Wang, Z. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01832-0 · Cited by 68 · see citing works

Targeting CGRP for migraine treatment: mechanisms, antibodies, small molecules, perspectives

Matteis, E. D., Guglielmetti, M., Ornello, R., Spuntarelli, V., Martelletti, P., & Sacco, S. (2020) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2020.1772758 · Cited by 66 · see citing works

GBD2021: headache disorders and global lost health – a focus on children, and a view forward

Steiner, T. J., Husøy, A. K., & Stovner, L. J. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01795-2 · Cited by 65 · see citing works

Acute headache management in emergency department. A narrative review

Giamberardino, M. A., Affaitati, G., Costantini, R., Guglielmetti, M., & Martelletti, P. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-019-02266-2 · Cited by 64 · see citing works

The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study

Waliszewska‐Prosół, M., Montisano, D. A., Antolak, M., Bighiani, F., Cammarota, F., Cetta, I., Corrado, M., Ihara, K., Kartamysheva, R., Petrušić, I., et al. (2024) · The Journal of Headache and Pain · doi:10.1186/s10194-024-01735-0 · Cited by 63 · see citing works

Migraine, Brain Glucose Metabolism and the “Neuroenergetic” Hypothesis: A Scoping Review

Moro, L. D., Rota, E., Pirovano, E., & Rainero, I. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.02.006 · Cited by 64 · see citing works

The Study of Pain in Rats and Mice

Larson, C. M., Wilcox, G. L., & Fairbanks, C. A. (2019) · Comparative Medicine · doi:10.30802/aalas-cm-19-000062 · Cited by 61 · see citing works

Migraine Pathophysiology

Qubty, W. F., & Patniyot, I. R. (2020) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.12.014 · Cited by 61 · see citing works

Pharmacologic Characterization of ALD1910, a Potent Humanized Monoclonal Antibody against the Pituitary Adenylate Cyclase-Activating Peptide

Loomis, C. M., Dutzar, B., Ojala, E. W., Hendrix, L., Karasek, C., Scalley-Kim, M. L., Mulligan, J., Fan, P., Billgren, J., Rubin, V., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.253443 · Cited by 59 · see citing works

Using Sleep Time Data from Wearable Sensors for Early Detection of Migraine Attacks

Siirtola, P., Koskimäki, H., Mönttinen, H., & Röning, J. (2018) · Sensors · doi:10.3390/s18051374 · Cited by 57 · see citing works

Migraine in the workplace

de Dhaem, O. B., & Sakai, F. (2022) · eNeurologicalSci · doi:10.1016/j.ensci.2022.100408 · Cited by 56 · see citing works

Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine—a meta-analysis

Sazali, S., Badrin, S., Norhayati, M. N., & Idris, N. S. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-039358 · Cited by 54 · see citing works

Migraine symptoms, healthcare resources utilization and disease burden in a large Polish migraine cohort

Waliszewska‐Prosół, M., Straburzyński, M., Czapińska-Ciepiela, E., Nowaczewska, M., Gryglas‐Dworak, A., & Budrewicz, S. P. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01575-4 · Cited by 54 · see citing works

Heartrate variability biofeedback for migraine using a smartphone application and sensor: A randomized controlled trial

Minen, M. T., Corner, S. E., Berk, T., Levitan, V., Friedman, S., Adhikari, S., & Seng, E. (2021) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2020.12.008 · Cited by 52 · see citing works

Current clinical practice in disabling and chronic migraine in the primary care setting: results from the European My-LIFE anamnesis survey

Ryvlin, P., Владимирович, С. К., Negro, A., la Rosa, R. S.-D., Israel-Willner, H., Sundal, C., MacGregor, E. A., & Peral, Á. L. G. (2021) · BMC Neurology · doi:10.1186/s12883-020-02014-6 · Cited by 53 · see citing works

Pharmacologic Characterization of ALD403, a Potent Neutralizing Humanized Monoclonal Antibody Against the Calcitonin Gene-Related Peptide

Garcı́a-Martı́nez, L. F., Raport, C. J., Ojala, E. W., Dutzar, B., Anderson, K., Stewart, E., Kovacevich, B. R., Baker, B., Billgren, J., Scalley-Kim, M. L., et al. (2020) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.264671 · Cited by 52 · see citing works

Randomized controlled studies evaluating Topiramate, Botulinum toxin type A, and mABs targeting CGRP in patients with chronic migraine and medication overuse headache: A systematic review and meta-analysis

Giri, S., Tronvik, E., Linde, M., Pedersen, S. A., & Hagen, K. (2023) · Cephalalgia · doi:10.1177/03331024231156922 · Cited by 52 · see citing works

Non-Pharmacological Approaches to Headaches: Non-Invasive Neuromodulation, Nutraceuticals, and Behavioral Approaches

Grazzi, L., Toppo, C., D’Amico, D., Leonardi, M., Martelletti, P., Raggi, A., & Guastafierro, E. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18041503 · Cited by 52 · see citing works

United States Patients’ Perspective of Living With Migraine: Country‐Specific Results From the Global “My Migraine Voice” Survey

Gibbs, S. N., Shah, S., Deshpande, C. G., Bensink, M. E., Broder, M. S., Dumas, P. K., Buse, D. C., Vo, P., & Schwedt, T. J. (2020) · Headache: The Journal of Head and Face Pain · doi:10.1111/head.13829 · Cited by 50 · see citing works

A causal effects of gut microbiota in the development of migraine

He, Q., Wang, W., Xiong, Y., Tao, C., Ma, L., Ma, J., You, C., Anttila, V., Artto, V., Belin, A. C., et al. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01609-x · Cited by 52 · see citing works

Vitamin D3 might improve headache characteristics and protect against inflammation in migraine: a randomized clinical trial

Ghorbani, Z., Togha, M., Rafiee, P., Ahmadi, Z. S., Rasekhmagham, R., Djalali, M., Shahemi, S., Martami, F., Zareei, M., Jahromi, S. R., et al. (2020) · Neurological Sciences · doi:10.1007/s10072-019-04220-8 · Cited by 51 · see citing works

Quality of life of migraine patients followed in neurology clinics in Riyadh, Saudi Arabia

Al-Ateeq, M., & AlHarbi, F. (2020) · Journal of Family and Community Medicine · doi:10.4103/jfcm.jfcm_185_19 · Cited by 51 · see citing works

Vancouver Declaration on Global Headache Patient Advocacy 2018

Dodick, D. W., Edvinsson, L. I., Makino, T., Grisold, W., Sakai, F., Jensen, R., Balch, A. J., de la Torre, E. R., Lorenz, D. H., Craven, A., et al. (2018) · Cephalalgia · doi:10.1177/0333102418781644 · Cited by 50 · see citing works

Structured headache services as the solution to the ill-health burden of headache. 3. Modelling effectiveness and cost-effectiveness of implementation in Europe: findings and conclusions

Tinelli, M., Leonardi, M., Paemeleire, K., Raggi, A., Mitsikostas, D. D., de la Torre, E. R., & Steiner, T. J. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01305-8 · Cited by 50 · see citing works

Ubrogepant for the treatment of migraine

Curto, M., Capi, M., Cipolla, F., Cisale, G. Y., Martelletti, P., & Lionetto, L. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2020.1721462 · Cited by 49 · see citing works

Headache in the Global Burden of Disease (GBD) Studies

Stovner, L. J., Nichols, E. L., Steiner, T. J., & Vos, T. (2019) · Headache · doi:10.1007/978-3-030-24728-7_9 · Cited by 48 · see citing works

The Global Campaign turns 18: a brief review of its activities and achievements

Steiner, T. J., Birbeck, G. L., Jensen, R., Martelletti, P., Stovner, L. J., Uludüz, D., Leonardi, M., Olesen, J., & Katsarava, Z. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01420-0 · Cited by 46 · see citing works

Safety and tolerability of eptinezumab in patients with migraine: a pooled analysis of 5 clinical trials

Smith, T. R., Spierings, E. L. H., Cady, R. K., Hirman, J., Schaeffler, B. A., Shen, V., Sperling, B., Brevig, T., Josiassen, M. K., Brunner, E., et al. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01227-5 · Cited by 46 · see citing works

Burden of Migraine in Patients With Preventive Treatment Failure Attending European Headache Specialist Centers: Real-World Evidence From the BECOME Study

Pozo‐Rosich, P., Lucas, C., Watson, D. P. B., Gaul, C., Ramsden, E., Ritter, S., Martelletti, P., & Snellman, J. (2021) · Pain and Therapy · doi:10.1007/s40122-021-00331-3 · Cited by 45 · see citing works

Prolactin signaling modulates stress‐induced behavioral responses in a preclinical mouse model of migraine

Mason, B. N., Kallianpur, R., Price, T. J., Akopian, A. N., & Dussor, G. O. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14248 · Cited by 50 · see citing works

Monitoring chronic headache and medication-overuse headache prevalence in Denmark

Westergaard, M. L., Lau, C. J., Allesøe, K., Gjendal, S. T., & Jensen, R. H. (2020) · Cephalalgia · doi:10.1177/0333102419876909 · Cited by 44 · see citing works

Acute sleep deprivation enhances susceptibility to the migraine substrate cortical spreading depolarization

Negro, A., Seidel, J. L., Houben, T., Yu, E. S., Rosen, I., Arreguin, A. J., Yalcin, N., Shorser-Gentile, L., Pearlman, L., Sadhegian, H., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01155-w · Cited by 45 · see citing works

Cortical spreading depression and meningeal nociception

Carneiro-Nascimento, S., & Levy, D. (2022) · Neurobiology of Pain · doi:10.1016/j.ynpai.2022.100091 · Cited by 43 · see citing works

Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials

Loo, L. S., Ailani, J., Schim, J. D., Baygani, S., Hundemer, H., Port, M. D., & Krege, J. H. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1032-x · Cited by 43 · see citing works

Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2

Mozafarihashjin, M., Togha, M., Ghorbani, Z., Farbod, A., Rafiee, P., & Martami, F. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01377-6 · Cited by 43 · see citing works

Burden of migraine in Finland: health care resource use, sick-leaves and comorbidities in occupational health care

Korolainen, M. A., Kurki, S. H., Lassenius, M. I., Toppila, I., Costa‐Scharplatz, M., Purmonen, T. T., & Nissilä, M. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0964-5 · Cited by 42 · see citing works

Atogepant Has No Clinically Relevant Effects on the Pharmacokinetics of an Ethinyl Estradiol/Levonorgestrel Oral Contraceptive in Healthy Female Participants

Ankrom, W., Xu, J., Vallee, M., Dockendorf, M. F., Armas, D. R., Boinpally, R., & Min, K. C. (2020) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1610 · Cited by 42 · see citing works

Headache service quality: the role of specialized headache centres within structured headache services, and suggested standards and criteria as centres of excellence

on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache, Steiner, T. J., Göbel, H., Jensen, R., Lampl, C., Paemeleire, K., Linde, M., Braschinsky, M., Mitsikostas, D. D., Gil‐Gouveia, R., et al. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-0970-7 · Cited by 42 · see citing works

Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment

Gazerani, P. (2019) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-019-00428-8 · Cited by 42 · see citing works

Trajectory of migraine-related disability following long-term treatment with lasmiditan: results of the GLADIATOR study

Lipton, R. B., Lombard, L., Ruff, D. D., Krege, J. H., Loo, L. S., Buchanan, A. S., Melby, T. E., & Buse, D. C. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01088-4 · Cited by 42 · see citing works

Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine

Driessen, M. T., Cohen, J. M., Thompson, S. F., Patterson‐Lomba, O., Seminerio, M. J., Carr, K., Totev, T. I., Sun, R., Yim, E., Mu, F., et al. (2022) · The Journal of Headache and Pain · doi:10.1186/s10194-022-01415-x · Cited by 42 · see citing works

Effect of fremanezumab on quality of life and productivity in patients with chronic migraine

Lipton, R. B., Cohen, J. M., Gandhi, S. K., Yang, R., Yeung, P. P., & Buse, D. C. (2020) · Neurology · doi:10.1212/wnl.0000000000010000 · Cited by 41 · see citing works

Shaping the future of migraine targeting Calcitonin-Gene-Related-Peptide with the Disease-Modifying Migraine Drugs (DMMDs)

Martelletti, P., Edvinsson, L. I., & Ashina, M. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1009-9 · Cited by 40 · see citing works

Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process

Steiner, T. J., Terwindt, G. M., Katsarava, Z., Pozo-Rosich, P., Gantenbein, A. R., Roche, S. L., Dell’Agnello, G., & Tassorelli, C. (2022) · Cephalalgia · doi:10.1177/03331024221110102 · Cited by 39 · see citing works

Manual joint mobilisation techniques, supervised physical activity, psychological treatment, acupuncture and patient education in migraine treatment. A systematic review and meta-analysis

Beier, D., Edemann-Callesen, H., Carlsen, L. N., Birkefoss, K., Tómasdóttir, H., Würtzen, H., Christensen, H. W., Krøll, L. S., Jensen, M. T., Høst, C. V., et al. (2021) · Cephalalgia · doi:10.1177/03331024211034489 · Cited by 39 · see citing works

Consensus of the Hellenic Headache Society on the diagnosis and treatment of migraine

Hellenic Headache Society, Kouremenos, E., Arvaniti, C., Constantinidis, T. S., Giannouli, E., Fakas, N., Kalamatas, T., Kararizou, E. G., Naoumis, D., & Mitsikostas, D. D. (2019) · The Journal of Headache and Pain · doi:10.1186/s10194-019-1060-6 · Cited by 39 · see citing works

The effects of vitamin D supplementation on interictal serum levels of calcitonin gene-related peptide (CGRP) in episodic migraine patients: post hoc analysis of a randomized double-blind placebo-controlled trial

Ghorbani, Z., Rafiee, P., Fotouhi, A., Haghighi, S., Rasekhmagham, R., Ahmadi, Z. S., Djalali, M., Zareei, M., Jahromi, S. R., Shahemi, S., et al. (2020) · The Journal of Headache and Pain · doi:10.1186/s10194-020-01090-w · Cited by 39 · see citing works

A rational approach to migraine diagnosis and management in primary care

Martin, V. T., Feoktistov, A., & Solomon, G. D. (2021) · Annals of Medicine · doi:10.1080/07853890.2021.1995626 · Cited by 38 · see citing works

Efficacy and Safety of Rimegepant 75 mg Oral Tablet, a CGRP Receptor Antagonist, for the Acute Treatment of Migraine: A Randomized, Double-Blind, Placebo-Controlled Trial

Lipton, R. B., Thiry, A., Morris, B., & Croop, R. S. (2024) · Journal of Pain Research · doi:10.2147/jpr.s453806 · Cited by 38 · see citing works

Burden of migraine and unmet needs from the patients’ perspective: a survey across 11 specialized headache clinics in Korea

Kim, B., Chu, M. K., Yu, S. J., Dell’Agnello, G., Han, J. H., & Cho, S. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01250-6 · Cited by 38 · see citing works

Baseline Brain Gray Matter Volume as a Predictor of Acupuncture Outcome in Treating Migraine

Yang, X., Liu, L., Xu, Z., Zhang, Y., Liu, D., Fishers, M., Zhang, L., Sun, J., Liu, P., Zeng, X., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00111 · Cited by 37 · see citing works

Acupuncture and Its Role in the Treatment of Migraine Headaches

Urits, I., Patel, M., Putz, M. E., Monteferrante, N. R., Nguyen, D., An, D., Cornett, E. M., Hasoon, J. J., Kaye, A. D., & Viswanath, O. (2020) · Neurology and Therapy · doi:10.1007/s40120-020-00216-1 · Cited by 37 · see citing works

Atogepant Is Not Associated With Clinically Meaningful Alanine Aminotransferase Elevations in Healthy Adults

Min, K. C., Kraft, W. K., Bondiskey, P., Colón‐González, F., Liu, W., Xu, J., Panebianco, D. L., Mixson, L. A., Dockendorf, M. F., Matthews, C. Z., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12917 · Cited by 36 · see citing works

miR‐34a‐5p up‐regulates the IL‐1β/COX2/PGE2 inflammation pathway and induces the release of CGRP via inhibition of SIRT1 in rat trigeminal ganglion neurons

Zhang, H., Zhang, X., Zong, D., Ji, X., Jiang, H., Zhang, F., & He, S. (2020) · FEBS Open Bio · doi:10.1002/2211-5463.13027 · Cited by 36 · see citing works

Measurement properties of the Headache Impact Test (HIT‐6™ Brazil) in primary and secondary headaches

Pradela, J., Bevilaqua‐Grossi, D., Chaves, T. C., Dach, F., & Carvalho, G. F. (2021) · Headache The Journal of Head and Face Pain · doi:10.1111/head.14049 · Cited by 37 · see citing works

Astrocytes mediate migraine-related intracranial meningeal mechanical hypersensitivity

Zhao, J., Blaeser, A. S., & Levy, D. (2021) · Pain · doi:10.1097/j.pain.0000000000002229 · Cited by 35 · see citing works

Structured headache services as the solution to the ill-health burden of headache. 2. Modelling effectiveness and cost-effectiveness of implementation in Europe: methodology

Tinelli, M., Leonardi, M., Paemeleire, K., Mitsikostas, D. D., de la Torre, E. R., & Steiner, T. J. (2021) · The Journal of Headache and Pain · doi:10.1186/s10194-021-01310-x · Cited by 36 · see citing works

Comparison of healthcare resource utilization and costs among patients with migraine with potentially adequate and insufficient triptan response

Marcus, S. C., Shewale, A. R., Silberstein, S. D., Lipton, R. B., Young, W. B., Viswanathan, H. N., & Doshi, J. A. (2020) · Cephalalgia · doi:10.1177/0333102420915167 · Cited by 35 · see citing works

The socioeconomic burden of migraine: An evaluation of productivity losses due to migraine headaches based on a population study in Germany

Seddik, A. H., Branner, J. C., Ostwald, D. A., Schramm, S. H., Bierbaum, M., & Katsarava, Z. (2020) · Cephalalgia · doi:10.1177/0333102420944842 · Cited by 34 · see citing works

Effectiveness of a manual therapy protocol based on articulatory techniques in migraine patients. A randomized controlled trial

Muñoz‐Gómez, E., Inglés, M., Serra‐Añó, P., & Espí‐López, G. V. (2021) · Musculoskeletal Science and Practice · doi:10.1016/j.msksp.2021.102386 · Cited by 34 · see citing works

GBD 2015: migraine is the third cause of disability in under 50s

Steiner, T. J., Stovner, L. J., & Vos, T. (2016) · The Journal of Headache and Pain · doi:10.1186/s10194-016-0699-5 · Cited by 267 · see citing works

National Healthcare Plans For Headache?

Steiner, T. J. (2007) · doi:10.1093/oso/9780199296569.003.0041 · Cited by 1 · see citing works

Migraine is the highest disabler among neurological disorders

de Lima, T. A. C. (2020) · Headache Medicine/Revista Headache Medicine · doi:10.48208/headachemed.2020.29

The pathophysiology of migraine

Pillai, S., & Moskatel, L. S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-95313-9.00020-4

Migraine matters

Neurology, T. L. (2021) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00334-3 · Cited by 3 · see citing works